Print

Publications

Posted in Dissemination

  • Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jørgensen T, Thorand B, Peters A, Nauck M, Petersmann A, Vartiainen E, Veronesi G, Brambilla P, Costanzo S, Iacoviello L, Linden G, Yarnell J, Patterson CC, Everett BM, Ridker PM, Kontto J, Schnabel RB, Koenig W, Kee F, Zeller T, Kuulasmaa K; BiomarCaRE Investigators(2016): Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J, [Epub ahead of print].
    PubMed    Open Access

  • Dankowski T, Ziegler A (2016): Calibrating random forests for probability estimation. Stat Med., [2016 Apr 13 [Epub ahead of print].

  • Everett BM, Zeller T, Glynn RJ, Ridker PM, Blankenberg S (2015): High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation, 131(21), 1851-60 .
    PubMed    Open Access

  • Ferrario MM, Veronesi G, Chambless LE, Tunstall-Pedoe H, Kuulasmaa K, Salomaa V, Borglykke A, Hart N, Söderberg S, Cesana G; for the MORGAM Project (2014): The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component. Heart, 100(15):1179-87.
    PubMed

  • Funke-Kaiser A, Havulinna, AS, Zeller T, Appelbaum S, Jousilahti P, Vartiainen E, Blankenberg S, Sydow K, Salomaa V (2014): Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort. Annals of Medicine, 46(3), 155-62.
    PubMed

  • Hughes MF, Appelbaum S, Havulinna AS, Jagodzinski A, Zeller T, Kee F, Blankenberg S, Salomaa V (2014): ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality in the population-based FINRISK 1997 cohort and the BiomarCaRE project. Heart, 100(21), 1715-1721.
    PubMed

  • Jagodzinski A, Havulinna AS, Appelbaum S, Zeller T, Jousilahti P, Skytte-Johanssen S, Hughes MF, Blankenberg S, Salomaa V (2015): Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort. Int J Cardiol., 192, 33-9.
    PubMed

  • Leitsalu L, Haller T, Esko T, Tammesoo ML, Alavere H, Snieder H, Perola M, Ng PC, Mägi R, Milani L, Fischer K, Metspalu A (2015): Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol, 44(4), 1137-47.
    PubMed

  • Milani L1, Leitsalu L, Metspalu A (2015): An epidemiological perspective of personalized medicine: the Estonian experience. J Intern Med., 277(2), 188-200.
    PubMed    Open Access

  • Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, de Groot L, Freedman ND, Jansen E, Kee F, Kromhout D, Kuulasmaa K, Laatikainen T, O'Doherty MG, Bueno-de-Mesquita B, Orfanos P, Peters A, van der Schouw YT, Wilsgaard T, Wolk A, Trichopoulou A, Boffetta P, Brenner H; CHANCES Consortium (2015): Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ, 350, h1551.
    PubMed    Open Access

  • Müezzinler A, Mons U, Gellert C, Schöttker B, Jansen E, Kee F, O'Doherty MG, Kuulasmaa K, Freedman ND, Abnet CC, Wolk A, Håkansson N, Orsini N, Wilsgaard T, Bueno-de-Mesquita B, van der Schouw YT, Peeters PH, de Groot LC, Peters A, Orfanos P, Linneberg A, Pisinger C, Tamosiunas A, Baceviciene M, Luksiene D, Bernotiene G, Jousilahti P, Petterson-Kymmer U, Jansson JH, Söderberg S, Eriksson S, Jankovic N, Sánchez MJ, Veronesi G, Sans S, Drygas W, Trichopoulou A, Boffetta P, Brenner H (2015): Smoking and All-cause Mortality in Older Adults: Results From the CHANCES Consortium. Am J Prev Med., 49(5), e53-63.
    PubMed

  • Neumann JT, Havulinna AS, Zeller T, Appelbaum S, Kunnas T, Nikkari S, Jousilahti P, Blankenberg S, Sydow K, Salomaa V (2014): Comparison of Three Troponins as Predictors of Future Cardiovascular Events – Prospective Results from the FINRISK and BiomaCaRE Studies. PLoS ONE, 9(3):e90063.
    PubMed    Open Access

  • Ordóñez-Mena JM, Schöttker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, O'Doherty MG, Scott A, Kee F, Stricker BH, Hofman A, de Keyser CE, Ruiter R, Söderberg S, Jousilahti P, Kuulasmaa K, Freedman ND, Wilsgaard T, de Groot LC, Kampman E, Håkansson N, Orsini N, Wolk A, Nilsson LM, Tjønneland A, Pająk A, Malyutina S, Kubínová R, Tamosiunas A, Bobak M, Katsoulis M, Orfanos P, Boffetta P, Trichopoulou A, Brenner H; Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) (2016): Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med., 14(1), 62.
    PubMed    Open Access

  • Siemelink M, Zeller T (2014): Biomarkers of Coronary Artery Disease – The promise of the transcriptome. Current Cardiology Reports, 16(8), 513.
    PubMed

  • Stitziel NO, Stirrups KE, Masca NG, Erdmann J, Ferrario PG, König IR, Weeke PE, Webb TR, Auer PL, Schick UM, Lu Y, Zhang H, Dube MP, Goel A, Farrall M, Peloso GM, Won HH, Do R, van Iperen E, Kanoni S, Kruppa J, Mahajan A, Scott RA, Willenborg C, Braund PS, van Capelleveen JC, Doney AS, Donnelly LA, Asselta R, Merlini PA, Duga S, Marziliano N, Denny JC, Shaffer CM, El-Mokhtari NE, Franke A, Gottesman O, Heilmann S, Hengstenberg C, Hoffmann P, Holmen OL, Hveem K, Jansson JH, Jöckel KH, Kessler T, Kriebel J, Laugwitz KL, Marouli E, Martinelli N, McCarthy MI, Van Zuydam NR, Meisinger C, Esko T, Mihailov E, Escher SA, Alver M, Moebus S, Morris AD, Müller-Nurasyid M, Nikpay M, Olivieri O, Perreault LP, AlQarawi A, Robertson NR, Akinsanya KO, Reilly DF, Vogt TF, Yin W, Asselbergs FW, Kooperberg C, Jackson RD, Stahl E, Strauch K, Varga TV, Waldenberger M, Zeng L, Kraja AT, Liu C, Ehret GB, Newton-Cheh C, Chasman DI, Chowdhury R, Ferrario M, Ford I, Jukema J, Kee F, Kuulasmaa K, Nordestgaard BG, Perola M, Saleheen D, Sattar N, Surendran P, Tregouet D, Young R, Howson JM, Butterworth AS, Danesh J, Ardissino D, Bottinger EP, Erbel R, Franks PW, Girelli D, Hall AS, Hovingh G, Kastrati A, Lieb W, Meitinger T, Kraus WE, Shah SH, McPherson R, Orho-Melander M, Melander O, Metspalu A, Palmer CN, Peters A, Rader DJ, Reilly MP, Loos RJ, Reiner AP, Roden DM, Tardif JC, Thompson JR, Wareham NJ, Watkins H, Willer CJ, Kathiresan S, Deloukas P, Samani NJ, Schunkert H (2016): Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med., 374(12), 1134-44.
    PubMed

  • Tunstall-Pedoe H, Woodward M, Hughes M, Anderson A, Kennedy G, Belch J, Kuulasmaa K; MORGAM Investigators. (2015): Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC). Int J Epidemiol, 44(5), 1602-12.
    PubMed    Open Access

  • Veronesi G, Ferrario MM, Kuulasmaa K, Bobak M, Chambless LE, Salomaa V, Soderberg S, Pajak A, Jørgensen T, Amouyel P, Arveiler D, Drygas W, Ferrieres J, Giampaoli S, Kee F, Iacoviello L, Malyutina S, Peters A, Tamosiunas A, Tunstall-Pedoe H, Cesana G (2016): Educational class inequalities in the incidence of coronary heart disease in Europe.. Heart., [2016 Feb 5 Epub ahead of print] .
    PubMed

  • Wright MN, Ziegler A (2016): ranger: A Fast Implementation of Random Forests for High Dimensional Data in C++ and R. estimation. J Stat Softw, in press.

  • Wright MN, Ziegler A, König IR (2016): Do little interactions get lost in dark random forests? BMC Bioinformatics., 17, 145.
    PubMed    Open Access

  • Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, Ruijter HD, Schnabel RB, Kee F, Salomaa V, Siebert U, Thorand B, Ziegler A, Breek H, Pasterkamp G, Kuulasmaa K, Koenig W, Blankenberg S (2014): BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol, 29(10):777-90.
    PubMed    Open Access

  • Zeller T, Keller T, Ojeda F, Reichlin T, Twerenbold R, Tzikas S, Wild PS, Reiter M, Czyz E, Lackner KJ, Munzel T, Mueller C, Blankenberg S. (2014): Assessment of microRNAs in patients with unstable angina pectoris. Eur Heart J, 35(31):2106-14.
    PubMed    Open Access

  • Zeller T, Ojeda F, Brunner FJ, Peitsmeyer P, Münzel T, Binder H, Pfeiffer N, Michal M, Wild PS, Blankenberg S, Lackner KJ (2014): High-sensitivity cardiac troponin I in the general population - defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med, 53(5), 699-706.
    PubMed

  • Zeller T, Tunstall-Pedoe H, Saarela O, Ojeda F, Schnabel RB, Tuovinen T, Woodward M, Struthers A, Hughes M, Kee F, Salomaa V, Kuulasmaa K, Blankenberg S; MORGAM Investigators (2014): High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J., 35(5), 271-81.
    PubMed    Open Access